v3.22.4
Revenue and Expenses (Details) - Schedule of revenue and expenses - AUD ($)
 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Other revenue:    
Consultancy income $ 60,390 $ 17,302
Grant income   37,500
License revenue   500,000
Joint venture income 172,170 553,185
Other income 13,409 1,000
Total Other revenue 245,969 1,108,987
General administration    
Amortisation & depreciation expense 363,695 349,387
Unrealised foreign exchange (gain) / loss (137,374) (147,105)
Consulting & advisory 553,087 299,330
Corporate expenses 745,452 455,673
Telecommunications & IT 202,560 167,201
General & administration expenses 431,927 327,720
Outsourced development costs 164,050  
Subscription costs 266,844 21,738
Doubtful debts expense 235,357  
Insurance expense 1,343,312  
Other expenses 1,839,097 219,277
Total General administration 6,008,007 1,693,221
Provision for impairment expense    
Provision for impairment expense 1,524,752 2,812,687
Employee expenses    
Salaries and wages 3,429,019 2,830,510
Defined contribution superannuation 322,219 266,626
Share-based payments expense [1] 7,452,583 6,230,997
Employment taxes and insurances 435,089 523,903
Other employment expenses 123,400 196,175
Government grants – JobKeeper   (162,000)
Total Employee expenses 11,762,310 9,886,211
Triage Technologies Inc [Member]    
Provision for impairment expense    
Provision for impairment expense [2] 551,089 1,362,717
Jana Care Inc [Member]    
Provision for impairment expense    
Provision for impairment expense 62,129 690,153
Bearn Inc [Member]    
Provision for impairment expense    
Provision for impairment expense 803,072  
Body Composition Technologies Pte Ltd [Member]    
Provision for impairment expense    
Provision for impairment expense 188,271 680,008
Physimax Technologies Limited [Member]    
Provision for impairment expense    
Provision for impairment expense $ (79,809) $ 79,809
[1] The fair value of equity settled transactions with employees, directors and suppliers is apportioned over the period from grant date to vesting date. See Note 19 for details of transactions vesting within the financial year.
[2] Following the Valuation referred to in note 26 (i), the provision for impairment expense was reduced by A$2,565,082.